Christine Ryan
Clinical trials sponsored by Christine Ryan, explained in plain language.
-
New hope for mantle cell lymphoma: combo therapy aims to improve remission
Disease control Recruiting nowThis study tests a new combination of drugs (bendamustine, rituximab, cytarabine, and zanubrutinib) as initial treatment for mantle cell lymphoma, followed by a maintenance phase with or without an additional drug (sonrotoclax). The goal is to see if this approach leads to a comp…
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
New hope for aggressive blood cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a drug called glofitamab, alone or with other medicines, in people whose chronic lymphocytic leukemia has turned into a more aggressive lymphoma (Richter's transformation). About 70 adults will receive treatment to see if the cancer shrinks or disappears. The goa…
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 11, 2026 20:51 UTC